AMWL
American Well Corp
NYSE · Healthcare · Medical - Healthcare Information Services · US
$12.91
+1.33%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 162.2M | 249.3M | 254.4M | 259.0M | 277.2M |
| Cost of Revenue | 109.0M | 116.5M | 155.4M | 164.3M | 160.4M |
| Gross Profit | 53.3M | 132.9M | 99.0M | 94.8M | 116.8M |
| Operating Expenses | |||||
| R&D Expense | 46.3M | 72.9M | 86.1M | 105.8M | 138.5M |
| SG&A Expense | 99.0M | 131.3M | 197.4M | 213.1M | 228.0M |
| General & Admin Expense | 69.1M | 88.0M | 121.2M | 126.6M | 146.4M |
| Selling & Marketing Expense | 30.0M | 43.3M | 76.3M | 86.5M | 81.6M |
| Other Expenses | 16.3M | 34.0M | 33.0M | 468.0M | 26.2M |
| Total Operating Expenses | 161.6M | 238.1M | 316.5M | 786.9M | 392.6M |
| Cost and Expenses | 270.5M | 354.6M | 471.9M | 951.2M | 553.0M |
| Operating Income (EBIT) | (59.3M) | (105.3M) | (217.5M) | (692.1M) | (275.9M) |
| Non-Operating | |||||
| Interest Income | 313.0K | 3.8M | 10.8M | 19.4M | 6.1M |
| Interest Expense | 2.1M | — | — | — | — |
| Net Interest Income | (304.0K) | 3.8M | 10.8M | 19.4M | 6.1M |
| Other Non-Op Income/Expense | 3.1M | 10.7M | 7.6M | 16.8M | 3.8M |
| Non-Operating Income (excl Interest) | (1.6M) | (10.7M) | (7.6M) | (436.5M) | (3.8M) |
| EBT (Pre-Tax Income) | (56.2M) | (94.5M) | (209.9M) | (675.3M) | (272.0M) |
| Income Tax Expense | (1.7M) | 434.0K | 2.8M | 3.9M | 64.0K |
| Bottom Line | |||||
| Net Income | (57.1M) | (95.7M) | (208.1M) | (675.2M) | (270.4M) |
| Earnings from Cont. Ops | (56.5M) | (95.0M) | (212.6M) | (679.2M) | (272.1M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (57.1M) | (95.7M) | (208.1M) | (675.2M) | (270.4M) |
| Per Share | |||||
| Basic EPS | ($3.44) | ($5.96) | ($13.88) | ($47.50) | ($19.68) |
| Diluted EPS | ($3.44) | ($5.96) | ($13.88) | ($47.50) | ($19.68) |
| Revenue Per Share | $9.51 | $15.54 | $16.96 | $18.23 | $20.21 |
| Shares | |||||
| Basic Shares Outstanding | 17.1M | 16.0M | 15.0M | 14.2M | 13.7M |
| Diluted Shares Outstanding | 17.1M | 16.0M | 15.0M | 14.2M | 13.7M |
| Profitability Metrics | |||||
| EBITDA | (28.4M) | (60.6M) | (176.9M) | (224.2M) | (245.8M) |
| D&A | 28.3M | 34.0M | 33.0M | 31.5M | 26.2M |
| EBIT | (46.1M) | (94.5M) | (209.9M) | (255.7M) | (272.0M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026